[Bisphosphonate-induced osteonecrosis of the jaw in a patient with metastatic breast cancer]

Rev Esp Med Nucl. 2011 Sep-Oct;30(5):322-3. doi: 10.1016/j.remn.2010.12.001. Epub 2011 Mar 26.
[Article in Spanish]
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Bisphosphonate-Associated Osteonecrosis of the Jaw / diagnostic imaging*
  • Bisphosphonate-Associated Osteonecrosis of the Jaw / etiology
  • Bone Density Conservation Agents / adverse effects*
  • Bone Density Conservation Agents / therapeutic use
  • Bone Diseases, Metabolic / prevention & control
  • Bone Neoplasms / diagnostic imaging
  • Bone Neoplasms / drug therapy
  • Bone Neoplasms / secondary*
  • Breast Neoplasms / complications*
  • Breast Neoplasms / surgery
  • Carcinoma / diagnostic imaging
  • Carcinoma / secondary*
  • Diagnosis, Differential
  • Diphosphonates / adverse effects*
  • Diphosphonates / therapeutic use
  • Female
  • Humans
  • Imidazoles / adverse effects*
  • Imidazoles / therapeutic use
  • Mandibular Diseases / chemically induced
  • Mandibular Diseases / diagnostic imaging*
  • Mandibular Neoplasms / secondary
  • Middle Aged
  • Osteoarthritis / complications
  • Osteoarthritis / diagnostic imaging
  • Radionuclide Imaging
  • Spinal Neoplasms / diagnostic imaging
  • Spinal Neoplasms / drug therapy
  • Spinal Neoplasms / secondary
  • Thoracic Vertebrae / diagnostic imaging
  • Zoledronic Acid

Substances

  • Bone Density Conservation Agents
  • Diphosphonates
  • Imidazoles
  • Zoledronic Acid